Plasma NfL and Cognitive Functioning in Older Adults: The Moderating Role of HDL Cholesterol

HDL cholesterol moderates the association between plasma NfL and cognitive performance in older adults. Elevated HDL levels enhance the negative impact of NfL on cognition, challenging the assumption that HDL is uniformly protective in aging. As a modifiable factor, HDL offers a clinically actionable target in efforts to delay cognitive decline. These findings align with the United States Department of Health and Human Services (HHS) priorities on biomarker-based strategies and underscore the value of integrating metabolic and neurodegenerative biomarkers for improved cognitive risk profiling and targeted interventions.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70861_108232
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma NfL and Cognitive Functioning in Older Adults: The Moderating Role of HDL Cholesterol

Ganesh Muneshwar Babulal, Beau M. Ances, Carlos C Cruchaga, Yu Zhu et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Plasma NfL and Cognitive Functioning in Older Adults: The Moderating Role of HDL Cholesterol

Ganesh Muneshwar Babulal, Beau M. Ances, Carlos C Cruchaga, Yu Zhu, Semere Bekena, Steven E Arnold, Ramkrishna Kumar Singh
article en

Abstract

HDL cholesterol moderates the association between plasma NfL and cognitive performance in older adults. Elevated HDL levels enhance the negative impact of NfL on cognition, challenging the assumption that HDL is uniformly protective in aging. As a modifiable factor, HDL offers a clinically actionable target in efforts to delay cognitive decline. These findings align with the United States Department of Health and Human Services (HHS) priorities on biomarker-based strategies and underscore the value of integrating metabolic and neurodegenerative biomarkers for improved cognitive risk profiling and targeted interventions.

Alzheimer s & DementiaVol. 21(S7)
Harvard University (US), Washington University in St. Louis (US), University of Johannesburg (ZA), Massachusetts General Hospital (US), Hope Center for Neurological Disorders (US), Prevent Alzheimer’s Disease 2020 (US)
Quality Education
Openalex Percentile: Top 34%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.